Skip to content

Author

Xiangliang Liu

We have 4 of 80 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Ultra-processed food consumption and atherosclerosis risk: a prospective cohort study of UK Biobank

Ultra-processed foods (UPFs) have become dominant in modern diets, yet their relationship with atherosclerosis—the primary pathological basis of cardiovascular disease—remains inadequately characterized. We investigated the association between UPF consumption and incident atherosclerosis risk and explored underlyin...

Yi-Xin Zhao, Yu-Guang Li, Xiang-Liang Liu et al. · 0 citations
Review Open access Aug 2026

Circulating tumor DNA in lung cancer immunotherapy: prognostic marker today, predictive tool tomorrow?

Circulating tumor DNA (ctDNA) is emerging as a minimally invasive biomarker for risk stratification and treatment-response assessment in lung cancer immunotherapy, but its routine use for treatment selection has not been established. This review critically evaluates evidence across neoadjuvant, adjuvant, consolidation...

Yan Li, Guan-Yu Lu, Wei Song et al. · 0 citations
Review Jul 2026

Pulmonary nodule prediction in the multi-omics era: integrating radiomics, AI, liquid biopsy, and airway classifiers.

Low-dose CT (LDCT) lung cancer screening significantly reduces mortality but has dramatically increased the detection of pulmonary nodules. Most of these nodules are benign, leading to a high false-positive rate that triggers unnecessary invasive procedures and patient anxiety, underscoring the need for more precise no...

Yan Li, Guanyu Lu, Xiangliang Liu et al. · 0 citations
Review Aug 2026

The ER stress-autophagy axis in cancer-induced muscle wasting: Unveiling the IRE1α/XBP1 pathway as a therapeutic target.

This review examines how tumor-derived signals activate IRE1α/XBP1 to upregulate both the autophagy-lysosome pathway (ALP) and ubiquitin-proteasome system (UPS); its crosstalk with inflammatory and metabolic networks; and the therapeutic potential of IRE1α inhibitors, XBP1-directed strategies, and nutritional approache...

Guan-Ran Ding, Wang Yang, Yi-Xin Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.